561 filings
Page 7 of 29
4
MBRX
Moleculin Biotech Inc
23 Nov 22
Moleculin Biotech / WALTER V KLEMP ownership change
8:30am
4
Klemp Walter V
18 Nov 22
Moleculin Biotech / WALTER V KLEMP ownership change
8:34pm
8-K
MBRX
Moleculin Biotech Inc
14 Nov 22
Regulation FD Disclosure
8:00am
8-K
MBRX
Moleculin Biotech Inc
10 Nov 22
Moleculin Reports Third Quarter 2022 Financial Results and Provides Pipeline Update
4:11pm
10-Q
2022 Q3
MBRX
Moleculin Biotech Inc
Quarterly report
10 Nov 22
4:05pm
8-K
MBRX
Moleculin Biotech Inc
14 Oct 22
Moleculin Provides Update on Second Multiple Ascending Dose (MAD) Cohort in Phase 1a Clinical Trial of WP1122 in the UK
8:40am
8-K
MBRX
Moleculin Biotech Inc
27 Sep 22
Regulation FD Disclosure
8:36am
8-K
MBRX
Moleculin Biotech Inc
9 Sep 22
Regulation FD Disclosure
4:00pm
8-K
MBRX
Moleculin Biotech Inc
6 Sep 22
Moleculin Receives FDA Orphan Drug Designation of WP1122 for the Treatment of Glioblastoma Multiforme
8:45am
8-K
MBRX
Moleculin Biotech Inc
19 Aug 22
Moleculin Announces Completion of Third Single Ascending Dose (SAD) Cohort in Phase 1a Clinical Trial of WP1122 in the UK
8:40am
8-K
MBRX
Moleculin Biotech Inc
18 Aug 22
Regulation FD Disclosure
5:06pm
8-K
MBRX
Moleculin Biotech Inc
15 Aug 22
Moleculin Reports Second Quarter 2022 Financial Results and Provides Programs Update
8:48am
10-Q
2022 Q2
MBRX
Moleculin Biotech Inc
Quarterly report
12 Aug 22
5:01pm
8-K
MBRX
Moleculin Biotech Inc
28 Jul 22
Regulation FD Disclosure
8:35am
S-8
MBRX
Moleculin Biotech Inc
19 Jul 22
Registration of securities for employees
5:18pm
4/A
Klemp Walter V
15 Jul 22
Moleculin Biotech / WALTER V KLEMP ownership change
8:04pm
4/A
Klemp Walter V
15 Jul 22
Moleculin Biotech / WALTER V KLEMP ownership change
8:03pm
4/A
MBRX
Moleculin Biotech Inc
15 Jul 22
Moleculin Biotech / WALTER V KLEMP ownership change
8:03pm
4
MBRX
Moleculin Biotech Inc
13 Jul 22
Moleculin Biotech / WALTER V KLEMP ownership change
5:00pm
8-K
MBRX
Moleculin Biotech Inc
8 Jul 22
Cohort in Phase 1a Clinical Trial of WP1122 in the UK
8:37am